Introduction {#s1}
============

Biomineralization is the process that living organisms produce and maintain mineral tissues such as bones, cartilages and teeth. The mechanism related to the formation and homeostasis of those minerals is not well understood, but there is a strong belief that proteins play an important role [@pone.0042204-Hunter1]. In addition, phenomena related to mineral crystal growth inhibition, demineralization and remineralization are always related to protein adsorption on the surface of the mineral. These events are also common in dental enamel, a crystalline calcium phosphate mineral close in composition to hydroxyapatite.

Dental caries (tooth decay) is a complex disease, characterized by demineralization of tooth structure by bacterial organic acids from the dental biofilm supported by salivary proteins adsorbed on mineral tooth surface [@pone.0042204-Fejerskov1]. According to the World Health Organization (WHO), dental caries remains a major public health problem in most industrialized countries, affecting 60--90% of school children and the vast majority of adults. It is also the most prevalent oral disease in several Asian and Latin American countries [@pone.0042204-Petersen1].

Fluoride is well known to reduce dental caries by reducing the solubility and enhancing remineralization of dental enamel by the incorporation of available fluoride into the tooth structure during acid attacks [@pone.0042204-Featherstone1]. Basically, there are two forms to delivery and promote the benefits of fluoride on dental enamel. The self-administered methods of fluoride utilization include systemic application, for instance community water fluoridation, and topical application through daily use of fluoride dentifrices with concentration ranging from 1,000 to 1,500 ppm of fluoride. On the other hand, professional methods of fluoride utilization employ products in much higher concentration (ranging from 1% to 5% sodium fluoride). Professional fluoride applications have been effective complimentary methods to prevent and arrest caries progress, mainly in the patients with caries activity [@pone.0042204-Marinho1].

In addition to the positive effects of fluoride, several salivary proteins appear to be involved in inhibition of enamel demineralization and/or remineralization processes [@pone.0042204-Siqueira1],[@pone.0042204-Vitorino1],[@pone.0042204-Featherstone2],[@pone.0042204-Zahradnik1] with a protective role that depends on the selective adsorption of these salivary proteins onto the enamel surface of teeth. These proteins attached to the enamel surface form a thin protein layer called Acquired Enamel Pellicle (AEP) [@pone.0042204-Siqueira2], [@pone.0042204-Hannig1]. The AEP protects the tooth from enamel demineralization by acting as a natural diffusion barrier inhibiting direct contact between the tooth surfaces and oral bacteria acids [@pone.0042204-Hannig1], [@pone.0042204-Hara1]. More specifically, the AEP decreases diffusion rates of phosphate and calcium ions into the surrounding fluid following exposure of the tooth to acidic conditions, thus protecting against demineralization [@pone.0042204-Zahradnik2]. In addition, by virtue of its location, AEP is the interface between the mineral phase of dental enamel and the plaque, a biofilm largely composed of oral bacteria [@pone.0042204-Hannig1]. This biofilm is the key feature responsible for the development of dental caries and other oral diseases such as periodontitis. Since attachment of bacteria to the AEP is the earliest event in the bacterial colonization of enamel, the protein composition of AEP plays a critical role in the modulation of oral biofilm. This oral biofilm modulation can determine the balance between oral health and disease because specific salivary proteins promote adhesion and plaque formation of pathogenic bacteria [@pone.0042204-Vukosavljevic1].

Despite the importance of both fluoride and AEP to prevent dental caries, scarce information is available on the effects of fluoride on AEP formation. It is established that minimum changes in the chemical properties of solid surfaces such as hydroxyapatite have influence on the adsorption behavior of salivary proteins to the surfaces [@pone.0042204-Hay1], [@pone.0042204-Sonju1]. Several studies indicate that the topical use of fluoride on enamel results in the formation of a layer of calcium-fluoride (CaF~2~) like material, which strongly change the composition and chemical properties of the enamel surface [@pone.0042204-Buzalaf1]. The aim of this study was to investigate the effects of topical fluoride treatment on hydroxyapatite on the subsequent formation of AEP. In addition, this study pioneered the use of label-free quantitative proteomics for better understanding on the composition and function of AEP proteins.

Methods {#s2}
=======

Whole Saliva Collection {#s2a}
-----------------------

This study was approved by the Research Human Ethics Board of Western University (review number 16181E). Written informed consent was acquired from all subjects in this study. Whole saliva from 3 healthy subjects were collected between 9:00 and 11:00 A.M. under masticatory stimulation using Parafilm, 25 cm^2^ ∼1 g [@pone.0042204-Siqueira3]. The samples were kept on ice during the collection procedure, and immediately after collection centrifuged at 14,000×*g* for 20 min at 4°C. Whole saliva supernatants were separated from the pellet, a saliva pool was carried out and used immediately for the proposed analyses. The total protein concentration of whole saliva supernatant was measured by the bicinchoninic acid (BCA) assay (Pierce Chemical, Rockford, IL, USA) with bovine serum albumin used as the standard.

Incubation of Fluoride Treated HA Discs with Human Saliva {#s2b}
---------------------------------------------------------

To evaluate the effect of sodium fluoride (NaF) on adsorption of salivary protein on hydroxyapatite (HA) surface, HA discs (5 mm diameter×1 mm thickness, Clarkson Chromatography products, Inc.) were cleaned by 5 min sonication in distilled water. Forty HA discs were randomly divided in 4 groups (n = 10 per group). NaF solutions were prepared with distilled water and NaF (ACS chemical grade, 99% pure, BDH, West Chester, PA, USA) under constant agitation at 37°C for a period of 2 hours. Each disc was exposed to 300 µl of distilled water (control group) or 1% NaF (1% NaF group), 2% NaF (2% NaF group), and 5% NaF (5% NaF group) for a period of 2 h at 37°C with gentle agitation. After this period, the discs were washed in distilled water for 30 sec. Subsequently, the pre-treated discs were immersed into individual vials containing 100 µg of whole saliva supernatant for an additional period of 2 h at 37°C. Immediately after protein incubation period the discs were extensively washed using distilled water to remove any weak binding salivary protein.

Harvesting of *in vitro* AEP {#s2c}
----------------------------

AEP proteins formed on each HA disc over a 2 h period was collected by incubating with 150 µl of a solution containing 80% acetonitrile, 19.9% water and 0.1% TFA and sonicated for 5 min. This procedure was repeated three times to release all the mineral-associated protein or peptides for subsequent analyses and the 450 µl combined in a vial/disc. Eluted AEP material from each of the ten discs from the same group was pooled and concentrated by a rotary evaporator. The total protein concentration was assessed by the Micro Bicinchoninic acid (Micro BCA) assay.

In--solution Digestion {#s2d}
----------------------

Equal protein amount (10 µg) from both experimental and control groups were dried by a rotary evaporator, denatured and reduced for 2 h by the addition of 200 µl of 4 M urea, 10 mM dithiothreitol (DTT), and 50 mM NH~4~HCO~3~, pH 7.8. After four-fold dilution with 50 mM NH~4~HCO~3~, pH 7.8, tryptic digestion was carried out for 18 h at 37°C, after the addition of 2% (w/w) sequencing-grade trypsin (Promega, Madison, WI, USA).

Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS) {#s2e}
-------------------------------------------------------------------------------------

Peptide separation and mass spectrometric analyses were carried out with a nano-HPLC Proxeon (Thermo Scientific, San Jose, CA, USA) which allows in-line liquid chromatography with the capillary column, 75 µm×10 cm (Pico Tip™ EMITTER, New Objective, Woburn, MA) packed in-house using Magic C18 resin of 5 µm diameter and 200 Å pores size (Michrom BioResources, Auburn, CA) linked to mass spectrometer (LTQ-Velos, Thermo Scientific, San Jose, CA, USA) using an electrospray ionization in a survey scan in the range of m/z values 390--2000 tandem MS/MS. Equal amount of all samples were dried by rotary evaporator and re-suspended in 20 µl of 97.5 % H~2~O/2.4% acetonitrile/0.1% formic acid and then subjected to reversed-phase LC-ESI-MS/MS. The nano-flow reversed-phase HPLC was developed with linear 80 minutes gradient ranging from 5% to 55% of solvent B in 65 minutes (97.5% acetonitrile, 0.1% formic acid) at a flow rate of 300 nl/min with a maximum pressure of 280 bar. Electrospray voltage and the temperature of the ion transfer capillary were 1.8 kV and 250°C respectively. Each survey scan (MS) was followed by automated sequential selection of seven peptides for CID, with dynamic exclusion of the previously selected ions.

The obtained MS/MS spectra were searched against human protein databases (Swiss Prot and TrEMBL, Swiss Institute of Bioinformatics, Geneva, Switzerland, <http://ca.expasy.org/sprot/>) using SEQUEST algorithm in Proteome Discoverer 1.3 software (Thermo Scientific, San Jose, CA, USA). Search results were filtered for a False Discovery rate of 1% employing a decoy search strategy utilizing a reverse database. An addition inclusion criterion for positive identification of proteins was that the same protein passing the filter score from at least in three different MS analyses from the same group in a total of four MS analyses per group.

Integration and Relative Proteome Quantitation {#s2f}
----------------------------------------------

For quantitative proteome analysis, three MS raw files from each pooled group were analyzed using SIEVE software (Version 2.0 Thermo Scientific, San Jose, CA, USA). Signal processing was performed in a total of 12 MS raw files. The SIEVE experimental workflow was defined as "Control Compare Trend Analysis" where one class of samples are compared to one or more other class of samples. Here the control samples were compared to each of the samples that were treated with different percentages of NaF (1%, 2% and 5%). For the alignment step, a single MS raw file belonging to the HA group was selected as the reference file and all of the other files were adjusted to generate the best correlation to this reference file. After alignment, the feature detection and integration (or framing) process was performed using the MS level data with a feature called "Frames From MS2 Scans" only. When using this type of framing only MS mass-to-charge ratio (m/z) values that were associated with MS2 scan are used. Any m/z measurements that do not have MS2 were ignored. The parameters used consisted of a frame m/z width of 1500 ppm and a retention time width of 1.75 min. A total of 216,099 MS2 scans were present in all of the 12 RAW files that resulted in a total of 20,158 frames. Then peak integration was performed for each frame and these values were used for statistic analysis. Next, peptide sequences obtained from the database search using SEQUEST algorithm in Proteome Discoverer 1.3 were imported into SIEVE. A filter was applied to the peptide sequences during the import that eliminated all sequences with a Percolator q-value greater than 1% (false discovery rate). Peptides were grouped into proteins and a protein ratio and p-value were calculated. SIEVE uses a weighted average of the peptide intensities for the protein calculation. By using the weighted average, peptides with lower variance in their intensity measurements have a higher weight on the overall protein ratio. This is done to decrease variance in protein level quantities based on variance of the peptides that compose proteins. Only proteins observed in all four groups were quantified. HA group was used as our default group and all other three groups were compared with HA control group.

Relative abundance of an individual protein from HA group was considered significantly different protein level when the values observed were \<0.75 for decrease abundance or \> 1.25 for increase abundance, and a *p*-value \<0.05 as described [@pone.0042204-Duan1].

X-ray Photoelectron Spectroscopy (XPS) {#s2g}
--------------------------------------

The XPS analyses were carried out with a Kratos Axis Ultra spectrometer using a monochromatic Al K(alpha) source (15 mA, 14 kV). XPS can detect all elements except hydrogen and helium, probes the surface of the sample to a depth of 5--10 nm, and has detection limits ranging from 0.1 to 0.5 atomic percent depending on the element. The instrument work function was calibrated to give a binding energy (BE) of 83.96 eV for the Au 4f7/2 line for metallic gold and the spectrometer dispersion was adjusted to give a BE of 932.62 eV for the Cu 2p3/2 line of metallic copper. The Kratos charge neutralizer system was used on all specimens. Survey scan analyses were carried out with an analysis area of 300×700 µm and a pass energy of 160 eV. Spectra were analyzed using CasaXPS software (version 2.3.14).

Enzyme-linked Immunosorbent Assay (ELISA) {#s2h}
-----------------------------------------

ELISA microtiter plate (96-wells) was coated with 100 µl of AEP protein material from each group (10 µg/ml) at 37°C for 1 hour. The plate was then washed three times with 250 µl Tris Buffered Saline (TBS) per well and 200 µl TBST containing 3% BSA added to each well to block uncoated sites, and incubated overnight at 4°C. Primary anti statherin antibody (50 µl; 1∶1000 dilution, Abcam, ab97950, MA, USA) in TBST containing 1% BSA was added to each well and incubated at 37°C for 1.5 h, followed by washing three times, and incubation with horse radish peroxidase (HRP) linked anti-rabbit IgG antibody (100 µl; 1∶30000 dilution, ROCKLAND, PA, USA) in TBST containing 1% BSA. After incubation in the dark for 1 h at room temperature OPD (o-phenylenediamine dihydrochloride, Sigma-Aldrich, MO, USA) was added and product wasanalyzed spectrophotometrically at 490 nm. Statherin levels in each sample were determined by reference to a statherin standard curve and assessed by linear regression analysis. Statherin protein (Chinapeptide, Shanghai, China) purity and M^r^ 5380 were determined by mass spectrometry analysis. Analysis of variance and Student-Newman-Keuls test for pairwise comparisons was carried out to compare the values among the groups.

Results {#s3}
=======

HA Surface Characterization {#s3a}
---------------------------

XPS analyses of HA group and 5% NaF group are shown in [Figure 1](#pone-0042204-g001){ref-type="fig"}. The widescan spectrum of the control specimen shows the presence of calcium (342 eV) and phosphorus (128 eV). Treatment of the HA disc with 5% NaF shows additional fluoride peak at 685 eV binding energy. This binding energy at 685 eV supports the contention that fluoride is bound to calcium as CaF~2~ on the enamel surface. When the fluoride atoms % on the surface was measured and compared among the three groups that were treated with fluoride, the values were (mean ± standard deviation) 9.1±1.0 9.80.7 and 14.30.8 for groups 1% NaF, 2% NaF and 5% NaF respectively (Table 1). Atoms % of calcium and phosphorus were also acquired and Ca/P ratio were calculated to each group (Table 1).

![XPS wide scan spectrum of HA surface disc\
(**A**) **and HA surface disc pre-treated with 1 % NaF** (**B**)**, 2% NaF** (**C**) **and 5% NaF** (**D**)**.** Note: arrow indicates the fluoride peak at 685 eV binding energy.](pone.0042204.g001){#pone-0042204-g001}

10.1371/journal.pone.0042204.t001

###### Atoms % of Calcium, Fluoride and Phosphorus on the HA surface treated with NaF.

![](pone.0042204.t001){#pone-0042204-t001-1}

            Calcium    Fluoride   Phosphorus   Ratio Calcium/Phosphorus
  -------- ---------- ---------- ------------ --------------------------
  HA        16.8±0.4               9.8±0.7               1.71
  1% NaF    10.2±1.4   9.1±1.0     6.2±0.6               1.64
  2% NaF    12.2±0.3   9.8±0.7     7.9±0.7               1.55
  5% NaF    6.7±0.2    14.3±0.8    5.2±0.4               1.29

Mean ±SD.

AEP Proteome Identification and Quantification {#s3b}
----------------------------------------------

After AEP elution from HA surface and trypsinization, equal amount of peptides were subjected to nanoscale LC-ESI-MS/MS. A total of 4 runs per group were carried out. The base-peak chromatogram for reversed-phase chromatography monitored by the mass spectrometer represents the intensity of all peptide ions in the sample in a single scan. AEP proteome from all four different groups showed a consistent elution of protein/peptides range from 12 to 45 min ([Figure 2](#pone-0042204-g002){ref-type="fig"}). The peptide ions were identified by the SEQUEST search following the criteria as described in [Methods](#s2){ref-type="sec"}. For the proteome identification of the AEP formed on all four different conditions carried out in this study a total of 87 different proteins were identified in HA control group, 77 different proteins were identified in 1% NaF group, 76 different proteins were identified in 2% NaF group and 87 different proteins were identified in 5% NaF group ([Table 2](#pone-0042204-t002){ref-type="table"}). The majority of the proteins were identified in all four groups indicating a high overlap in AEP proteins ([Table 2](#pone-0042204-t002){ref-type="table"}). [Figure 3](#pone-0042204-g003){ref-type="fig"} shows a Venn diagram with the number of proteins from each group and their overlaps among the four groups. A total of 45 proteins were present in all four groups. 12 proteins were exclusively present in HA control group. 3 proteins were exclusively present in 1% NaF group. 6 proteins were exclusively present in 2% NaF group and other 19 proteins only present in 5% NaF ([Table 2](#pone-0042204-t002){ref-type="table"}; [Figure 3](#pone-0042204-g003){ref-type="fig"}).

![Examples of base-peak chromatograms of each studied group.\
Peptide separation was achieved using a nano-flow reverse-phase HPLC column, with gradient elution ranging from 5 to 55% solvent B in 65 min.](pone.0042204.g002){#pone-0042204-g002}

10.1371/journal.pone.0042204.t002

###### Salivary proteins identified on hydroxyapatite discs and hydroxyapatite discs treated with 1%, 2% and 5% NaF.

![](pone.0042204.t002){#pone-0042204-t002-2}

                                                          Acession number                                Protein name
  ------------------------------------------------------ ----------------- ------------------------------------------------------------------------
  **Proteins present in all groups**                          B1AN48                             Small proline-rich protein 3
                                                              P01036                                      Cystatin-S
                                                              P01037                                     Cystatin-SN
                                                              P01620                           Ig kappa chain V-III region SIE
                                                              P01777                           Ig heavy chain V-III region TEI
                                                              P01781                           Ig heavy chain V-III region GAL
                                                              P01833                          Polymeric immunoglobulin receptor
                                                              P01834                               Ig kappa chain C region
                                                              P01857                              Ig gamma-1 chain C region
                                                              P01871                                 Ig mu chain C region
                                                              P01876                              Ig alpha-1 chain C region
                                                              P01877                              Ig alpha-2 chain C region
                                                              P02808                                      Statherin
                                                              P02812                        Basic salivary proline-rich protein 2
                                                              P02814                   Submaxillary gland androgen-regulated protein 3B
                                                              P04075                           Fructose-bisphosphate aldolase A
                                                              P04080                                      Cystatin-B
                                                              P04264                                   Keratin, type II
                                                              P04745                                   Alpha-amylase 1
                                                              P05109                                   Protein S100-A8
                                                              P06702                                   Protein S100-A9
                                                              P06733                                    Alpha-enolase
                                                              P09211                              Glutathione S-transferase
                                                              P09228                                     Cystatin-SA
                                                              P0CG05                             Ig lambda-2 chain C regions
                                                              P11021                           78 kDa glucose-regulated protein
                                                              P12273                             Prolactin-inducible protein
                                                              P13645                                   Keratin, type I
                                                              P15515                                      Histatin-1
                                                              P23284                        Peptidyl-prolyl cis-trans isomerase B
                                                              P25311                              Zinc-alpha-2-glycoprotein
                                                              P29508                                      Serpin B3
                                                              P30740                             Leukocyte elastase inhibitor
                                                              P31025                                     Lipocalin-1
                                                              P35527                            Keratin, type I cytoskeletal 9
                                                              P54108                          Cysteine-rich secretory protein 3
                                                              P61626                                      Lysozyme C
                                                              Q96DA0                              Zymogen granule protein 16
                                                              B7Z4X2                                   Lactotransferrin
                                                              E7EMJ3                                   Lactoperoxidase
                                                              E7EMQ1                                Carbonic anhydrase VI
                                                              E7EQ46                               Uncharacterized protein
                                                              P02768                                       Albumin
                                                              E9PBV3                                      Suprabasin
                                                              F5GXH2                               Lactate dehydrogenase A
  **Proteins present in HA, 1%** **and 2% NaF groups**        B1AHN5                              Hsp70 interacting protein
                                                              P01009                                      Serpin A1
                                                              P01605                              Ig kappa chain V-I region
                                                              P02810                    Salivary acidic proline-rich phosphoprotein 1
                                                              P27482                                     Calmodulin 3
                                                              Q8IUK7                                     ALB protein
                                                              F5GYT4                                     Actin, beta
                                                              F5H0L3                           6-phosphogluconate dehydrogenase
  **Proteins present in HA, 2% and 5% NaF groups**            B4DRT4                      Phosphatidylethanolamine-binding protein 1
                                                              P02533                                    Cytokeratin-14
                                                              P0CG04                             Ig lambda-1 chain C regions
                                                              P13647                           Keratin, type II cytoskeletal 5
                                                              P35908                           Keratin, type II cytoskeletal 2
  **Proteins present in HA, 1% and 5% NaF groups**            B1ALW1                                     Thioredoxin
                                                              Q08188                     Protein-glutamine gamma-glutamyltransferase
                                                              Q8TDL5        Long palate, lung and nasal epithelium carcinoma-associated protein 1
                                                              E9PKG6                                    Nucleobindin 2
  **Proteins present in HA and 1% NaF groups**                E7EUT5                       Glyceraldehyde-3-phosphate dehydrogenase
                                                              P01034                                      Cystatin-C
                                                              P02787                                   Serotransferrin
                                                              P08493                                  Matrix Gla protein
                                                              P27797                                     Calreticulin
                                                              P81605                                    Preproteolysin
                                                              Q13765                                      NAC-alpha
                                                              Q6P5S2                                   protein C6orf58
                                                              P37802                                     transgelin-2
  **Protein present in HA and 2% NaF groups**                 P08779                           Keratin, type I cytoskeletal 16
  **Proteins present in HA and 5% NaF groups**                P01625                            Ig kappa chain V-IV region Len
                                                              Q86YZ3                                       Hornerin
                                                              Q8IWZ5                        Tripartite motif-containing protein 42
  **Proteins exclusively present in control group**           O00391                                 Sulfhydryl oxidase 1
                                                              P01597                              Ig kappa chain V-I region
                                                              P15924                                     Desmoplakin
                                                              P31949                                   Protein S100-A11
                                                              P62158                                      Calmodulin
                                                              Q02413                                     Desmoglein-1
                                                              Q16739                             Ceramide glucosyltransferase
                                                              Q6ZVX7                Non-specific cytotoxic cell receptor protein 1 homolog
                                                              Q8TDN4                                        Ik3-1
                                                              C9J0E4                                Cystatin A (stefin A)
                                                              E5RGE1                                   zeta polypeptide
                                                              E9PHI2                           Heat shock protein 90 kDa alpha
  **Proteins present in 1%, 2% and 5% NaF groups**            P01040                                      Cystatin-A
                                                              Q9HC84                                       Mucin-5B
                                                              F5GZ39                                     Ubiquitin C
                                                              F5H805                               Uncharacterized protein
  **Proteins present in 1% and 2% NaF groups**                P07108                               Acyl-CoA-binding protein
                                                              Q01469                              Fatty acid-binding protein
  **Proteins present in 1% and 5% NaF groups**                Q96DR5        Short palate, lung and nasal epithelium carcinoma-associated protein 2
                                                              E7EPA8                        Prolyl 4-hydroxylase, beta polypeptide
  **Proteins exclusively present in 1% NaF group**            P20930                                      Filaggrin
                                                              D6R9A6                            High mobility group protein B2
                                                              E9PLJ3                                      Cofilin 1
  **Proteins present in 2% and 5% NaF groups**                P01593                             Ig kappa chain V-I region AG
                                                              P01617                            Ig kappa chain V-II region TEW
                                                              P01765                           Ig heavy chain V-III region TIL
                                                              P18510                      Interleukin-1 receptor antagonist protein
                                                              E7EQR4                                        Ezrin
  **Proteins exclusively present in 2% NaF group**            B4E1H9                               Phosphoglycerate kinase
                                                              P16401                                     histone H1.5
                                                              P80748                             Ig lambda chain V-III region
                                                              Q567Q0                                    Cyclophilin A
                                                              E7EPW1                               Uncharacterized protein
                                                              B4DUA5                               Uncharacterized protein
  **Proteins exclusively present in 5% NaF group**            E9PF79                                   Pyruvate kinase
                                                              P00558                              Phosphoglycerate kinase 1
                                                              P04083                                      Annexin A1
                                                              P04406                       Glyceraldehyde-3-phosphate dehydrogenase
                                                              P05164                                   Myeloperoxidase
                                                              P07737                                      Profilin-1
                                                              P17931                                      Galectin-3
                                                              P23528                                      Cofilin-1
                                                              P26038                                        Moesin
                                                              P30040                      Endoplasmic reticulum resident protein 29
                                                              P52209                  6-phosphogluconate dehydrogenase, decarboxylating
                                                              Q5SX91                       GDP dissociation inhibitor 2 (Fragment)
                                                              Q5T8F0                                     Cathepsin L1
                                                              C9J8F3                               Uncharacterized protein
                                                              C9JMC5                               Uncharacterized protein
                                                              E7EQL7                               Uncharacterized protein
                                                              E9PFF2                                    Transketolase
                                                              F5H0N0                                    Actin, gamma 1
                                                              F5H8B6                                     Proteinase 3

![Venn diagram of AEP proteins identified in each group and across groups.](pone.0042204.g003){#pone-0042204-g003}

Relative proteomic quantification was carried out in the 45 proteins observed in all four groups. Differential display of MS/MS spectra was carried out using SIEVE software. A threshold for significant differential level was set up at variation higher or lower than the 25% protein level observed in the control group. None of the 45 proteins show a differential level between HA control group and 1% NaF group. On the other hand, 14 proteins showed a decrease level between HA control group and 2% NaF group and 1 protein showed an increase level. Comparison of the HA control group with 5% NaF group, demonstrated 19 proteins with a reduced protein level while 1 protein showed an increase ([Table 3](#pone-0042204-t003){ref-type="table"}).

10.1371/journal.pone.0042204.t003

###### AEP protein abundance ratios from 1% NaF, 2% NaF and 5% NaF groups.

![](pone.0042204.t003){#pone-0042204-t003-3}

  Accession Number                Protein Name                Ratio 1%NaF/HA     p     Ratio 2%NaF/HA     p     Ratio 5%NaF/HA     p
  ------------------ --------------------------------------- ---------------- ------- ---------------- ------- ---------------- -------
  P01620                 Ig kappa chain V-III region SIE           1.11        0.605        1.09        0.001        0.83        0.154
  B1AN48                  Small proline-rich protein 3             1.06        0.326        0.81        0.001        0.77        0.001
  B7Z4X2               highly similar to Lactotransferrin          0.79        0.001        0.84        0.001        0.88        0.001
  E7EMJ3                         Lactoperoxidase                   0.88        0.514        0.38        0.001        0.02        0.001
  E7EMQ1                      Carbonic anhydrase 6                 0.77        0.240        0.76        0.064        0.63        0.014
  E7EQ46                     Uncharacterized protein               0.93        0.989        0.89        0.006        1.02        0.374
  P02768                          Serum albumin                    0.85        0.132        0.67        0.001        0.62        0.001
  E9PBV3                           Suprabasin                      1.15        0.239        1.22        0.191        0.94        0.093
  F5GXH2                     Lactate dehydrogenase A               0.85        0.269        0.94        0.004        0.86        0.001
  P01036                           Cystatin S                      0.90        0.001        0.65        0.001        0.73        0.001
  P01037                           Cystatin SN                     0.77        0.001        0.62        0.001        0.56        0.001
  P01777                 Ig heavy chain VIII region TEI            0.89        0.847        0.82        0.006        0.71        0.001
  P01781                 Ig heavy chain VIII region GAL            1.01        0.968        0.94        0.896        1.09        0.966
  P01833                Polymeric immunoglobulin receptor          0.96        0.366        0.95        0.245        1.04        0.118
  P01834                     Ig kappa chain C region               0.85        0.001        0.88        0.001        0.78        0.001
  P01857                    Ig gamma 1 chain C region              0.94        0.256        0.81        0.068        0.78        0.001
  P01871                      Ig mu chain C region                 1.11        0.496        0.96        0.992        1.14        0.719
  P01876                    Ig alpha 1 chain C region              1.01        1.000        0.96        0.037        1.04        0.352
  P01877                    Ig alpha 2 chain C region              1.00        0.279        0.84        0.058        0.83        0.001
  P02808                            Statherin                      0.86        0.999        0.44        0.001        0.38        0.001
  P02812              Basic salivary proline rich protein 2        1.12        0.008        1.35        0.001        1.88        0.004
  P02814                     Proline-rich protein 3                0.76        0.001        0.83        0.013        0.72        0.001
  P04075                Fructose bisphosphate aldolase A           1.05        0.528        0.91        0.173        0.95        0.317
  P04080                           Cystatin B                      0.90        0.510        0.88        0.329        0.72        0.001
  P04264                 Keratin type II cytoskeletal 1            0.54        0.001        0.60        0.001        0.72        0.001
  P04745                         Alpha amylase 1                   0.95        0.935        0.60        0.049        0.72        0.004
  P05109                         Protein S100A8                    1.07        0.163        0.94        0.001        1.25        0.001
  P06702                         Protein S100A9                    1.16        0.001        1.03        0.001        1.04        0.001
  P06733                          Alpha enolase                    0.75        0.001        0.62        0.001        0.49        0.001
  P09211                   Glutathione S transferase P             0.85        0.586        0.76        0.039        0.81        0.122
  P09228                           Cystatin SA                     1.09        0.002        0.93        0.010        0.69        0.001
  P0CG05                   Ig lambda-2 chain C regions             0.92        0.001        0.83        0.935        0.96        0.222
  P11021                78 kDa glucose regulated protein           1.01        0.570        0.88        0.380        0.96        0.078
  P12273                   Prolactin inducible protein             0.86        0.986        0.86        0.933        0.89        0.461
  P13645                Keratin\_ type I cytoskeletal 10           0.66        0.000        0.61        0.001        0.60        0.001
  P15515                           Histatin 1                      0.90        0.001        0.60        0.001        0.58        0.001
  P23284               Peptidylprolyl cistrans isomerase B         1.10        0.001        1.01        0.993        1.06        0.513
  P25311                    Zinc alpha 2 glycoprotein              0.99        1.000        0.85        0.290        0.95        1.000
  P29508                            Serpin B3                      0.94        0.422        0.87        0.187        1.01        0.632
  P30740                  Leukocyte elastase inhibitor             0.96        0.905        0.79        0.001        1.02        0.141
  P31025                           Lipocalin 1                     0.92        0.808        0.83        0.006        0.97        0.964
  P35527                  Keratin type I cytoskeletal 9            0.57        0.000        0.55        0.001        0.68        0.001
  P54108                Cysteine rich secretory protein 3          1.00        0.013        0.69        0.001        0.65        0.001
  P61626                           Lysozyme C                      0.72        0.000        0.59        0.001        0.48        0.001
  Q96DA0              Zymogen granule protein 16 homolog B         0.79        0.250        0.70        0.002        0.52        0.002

Note. Ratio HA/HA was used as reference and the value for all proteins is 1.000. p: statistical p-value.

To validate the differential protein level identified by quantitative mass spectrometry approach, ELISA was carried out on statherin, the protein with well-known characteristics and functions in the oral cavity. By MS a significant reduced protein level was observed at high fluoride concentration compared to control HA-discs ([Table 3](#pone-0042204-t003){ref-type="table"}). By ELISA statherin contents were demonstrated to decrease from 1.43±0.08 µg/10 µg AEP total protein in the control HA disc, to 1.15±0.05, 0.78±0.06 and 0.58±0.02 in the 1%, 2%, 5% NaF groups, respectively ([Figure 4](#pone-0042204-g004){ref-type="fig"}).

![ELISA experiment with 10 µg/ml of AEP material for each group and anti-statherin antibody.\
Each bar represents the mean value ±SD of one experiment performed in triplicate.](pone.0042204.g004){#pone-0042204-g004}

Discussion {#s4}
==========

Topical fluoride treatment of the enamel surface may alter the chemical properties of the enamel surface by means of a Ca-F~2~ material covering the enamel surface [@pone.0042204-Ogaard1]. It was our observation that HA surface changes after the treatment with fluoride. XPS showed that HA incubated with fluoride change the atoms % on the surface ([Figure 1](#pone-0042204-g001){ref-type="fig"}). It was not surprise that according to the concentration of fluoride increase in the sample group, the atoms % of fluoride increase in the surface ([Table 1](#pone-0042204-t001){ref-type="table"}).

It is known that HA binds proteins through both calcium (positive) and phosphate (negative) sites on the surface [@pone.0042204-Kawasaki1], [@pone.0042204-Kawasaki2]. The previous studies using classical biochemical assays examined the binding and selectivity of salivary proteins on HA. As one of the major outcomes, phosphorylated and negative salivary proteins such as statherin, histatin 1, and acidic proline-rich protein (acidic PRP) have shown a strong affinity to HA and they are considered pellicle precursor proteins [@pone.0042204-AlHashimi1], [@pone.0042204-Jensen1], [@pone.0042204-Lendenmann1]. In addition, few studies had investigated the AEP composition of HA coated with fluoride. For example, amino acid analyses showed no major differences in the amino acid compositions between AEP collected from fluoride covered enamel and AEP collected from regular enamel [@pone.0042204-Rykke1] , but the salivary protein adsorption on enamel treated with fluoride was considerably reduced compared to the adsorption on untreated enamel surface [@pone.0042204-Rykke1], [@pone.0042204-Belcourt1]. Recent developments of sensitive proteomic methodologies have opened new avenues for the characterization of very-low-abundance biological samples such as AEP. Using this proteomic technology, we have used mass spectrometry to perform the first global proteome of human *in vivo* AEP. We identified 130 AEP proteins, which have been characterized according to origin, putative biological function, and possible role in AEP structure [@pone.0042204-Siqueira4]. In the present study we explored the use of this mass spectrometry technology in conjunction with proteome quantification approach to investigate the effects of fluoride treatment on HA on the subsequent formation of AEP.

AEP proteome from all four different treatment groups showed a consistent elution of protein/peptides over the range from 12 to 45 minutes ([Figure 2](#pone-0042204-g002){ref-type="fig"}), demonstrating a similarity among AEP protein/peptides presented in all four groups studied. This observation is in agreement with our previous *in vivo* AEP investigation where the majority of the peptides eluted with a similar retention time [@pone.0042204-Siqueira4], [@pone.0042204-Siqueira5] but the number of proteins identified here was less than in our previous *in vivo* AEP study. This discrepancy probably is due to the different proteomic approach utilized before. In relation to protein identification, however, there were a significant percentage of proteins (14%) that were identified only in the HA control group but was not found in any of the groups treated with NaF. On the other hand, 21% of the proteins identified in 5% NaF group was also not found in any other groups ([Table 2](#pone-0042204-t002){ref-type="table"}). This data reinforces the concept that AEP formation is based on selective adsorption of salivary proteins on enamel surface, since when we modified the HA surface with treatment of fluoride, the protein profile observed was also changed. Another very interesting observation was the absence of acidic PRP 1 in samples from 5 % NaF group. Acidic PRPs are charge negative salivary proteins that have high affinity to HA and are potent inhibitors of secondary calcium phosphate precipitation, which is in large part due to their two phosphate groups linked covalently to Ser residues in positions 8 and 22. Similar to acidic PRP 1, calmodulin which is a small calcium binding acidic protein with a ∼Mr of 17 kDa, was also not observed in the 5% NaF group. The importance of these observations is related to previous studies where acidic PRP 1 on HA promote bacterial adhesion of streptococcus mutans and actinomyces viscosus, both cariogenic and periodontal pathogenic bacteria respectively [@pone.0042204-Gibbons1], [@pone.0042204-Stenudd1]. In the same aspect, calmodulin is responsible for binding to Candida albicans, which is a major fungus related to oral candidiasis [@pone.0042204-Webb1]. This data suggests that treatment of HA with fluoride (at high concentration) qualitatively modulates AEP contents that may have a role in lowering the cariogenic potential of the AEP, not only because of decrease solubility of the HA but its reduced potential to support pathogenic bacteria.

In general, the most common used techniques for quantitative proteomic analyses are 2D-PAGE (two-dimensional gel electrophoresis) and/or 2DIGE (two-dimensional differential gel electrophoresis). However, these methods are limited in sensitivity, low protein dynamic range, reproducibility and visualization of proteins in the gel [@pone.0042204-Peng1]. Substitute techniques to 2D-PAGE and 2DIGE are non-PAGE procedures based on liquid chromatography, where relative or absolute quantification is performed using parameters of chromatogram and mass spectrometer. In addition, limited success for the quantification of proteins has been accomplished by using stable isotope labeling such as ICAT, SILAC, and iTRAQ. One of the main limitations of these methods is that full labeling of the proteins/peptides is rarely achieved and that different peptides incorporate the label at different rates that complicates data analysis.

Recently, label-free quantitation methods to be carried out in complex biological fluids such as saliva or blood are becoming more reliable [@pone.0042204-Siqueira6]. Label-free quantitative proteomics provides an alternative approach for studies of AEP formation under effect of different conditions providing a more comprehensive view of composition and function of AEP proteins. In this study, we pioneered the use of a label-free LC-ESI-MS/MS methodology to explore the relative quantitation of *in vitro* AEP formed on HA disc treated with different concentrations of fluoride. After AEP proteome identified and characterized in all four different groups, SIEVE technology was used to compare the AEP protein profile. Briefly, SIEVE is a label-free-differential expression package software that aligns the MS spectra over time from different experimental conditions (HA and NaF groups) and then determines feature in the data (m/z and retention time pairs) that differ across the different conditions [@pone.0042204-Sutton1]. A first step in the quantitative proteomic analysis by SIEVE is to promote an alignment of all mass spectrometry chromatograms ([Figure 5](#pone-0042204-g005){ref-type="fig"}). One of the mass spectrometry chromatogram is taking as default chromatogram. All other chromatograms will be compared with the default one. In our study, we selected a default chromatogram as one of the chromatograms from HA group. Thus, all other chromatograms were compared with the selected chromatogram from HA group. Coefficient correlation score values were acquired for each mass spectrometric chromatogram and mean score values were calculated for each group. The values were 0.858 to 1% NaF group, 0.859 to 2% NaF group and, 0.805 to 5% NaF. Interestingly, we observed that according to the concentration of fluoride increase in the sample group, the alignment value will become more distant than the default chromatogram from HA group (established score 1). This observation suggests a change in quantity and quality of protein/peptides according to the concentration of fluoride.

![Alignment results from 12 base-peak chromatograms (3 base-peak chromatograms per group) generated by SIEVE.\
Inset: example of an extracted mass chromatogram for a peptide whose abundance is increased in HA (Blue), 1% NaF(red), 2% NaF (violet) groups and decreased in 5% NaF group (green).](pone.0042204.g005){#pone-0042204-g005}

Relative proteomic quantification was carried out for the 45 proteins observed in all four groups. Notably, all 45 proteins showed no significant variation when the concentration of fluoride was 1% on the HA surface. On the other hand, it was surprising to found that 33% of those proteins show a significant difference protein level (higher or lower) in the group treated with 2% NaF and this value was increased to 45% when the HA was treated with 5% NaF. A detailed analysis of this AEP quantitative data shows that phosphorylated and negative salivary proteins with a crucial role on tooth enamel homeostasis were drastically affected with the incorporation of fluoride on the HA surface. We saw that according to the fluoride concentration was increased on the HA surface, the protein level of these proteins were reduced. For instance, values of statherin and histatin 1 between HA group and 5% NaF group were reduced by 62% and 42%, respectively ([Table 3](#pone-0042204-t003){ref-type="table"}). This shows a significant low abundance of statherin and histatin 1 when HA surface is coated with high concentration of fluoride. Our observation could be compared with the previous investigation, which shows that pre-treated HA crystals with high concentration fluoride blocked the positive charges (calcium) on the apatite surface resulting in reduced amelogenin binding, a phosphorylated and negative protein which is the dominant protein in the developing enamel matrix [@pone.0042204-Tanimoto1]. The importance of our observation is related to the function of these proteins. Statherin is a small molecular weight salivary protein with negative net charges that contain vicinal phosphoserine residues in positions 2 and 3. Statherin is the only salivary protein that inhibits both primary calcium phosphate precipitation (spontaneous precipitation) and secondary calcium phosphate precipitation (crystal growth), crucial functions related for the controlling of dental calculus formation and remineralization of early dental caries [@pone.0042204-Oppenheim1]. Beside, it has been demonstrated that statherin facilitates the binding of Actinomyces viscosus [@pone.0042204-Gibbons1], [@pone.0042204-Gibbons2], [@pone.0042204-Clark1] and Fusobacterium nucleatum [@pone.0042204-Xie1] to HA pre-coated with statherin indicating that statherin is determinant of initial microbial colonisation of tooth surface. Similar to statherin, histatin 1 is a salivary protein that exhibits the most varied of activities studied to date. The postulated *in vivo* functions for histatin 1 include buffering, modulation of mineral formation, as well as strong antifungal and antibacterial activities [@pone.0042204-Raj1], [@pone.0042204-Edgerton1]. In addition, a new feature for histatins has recently been identified. When histatins are adsorbed onto the enamel surface forming the AEP, these proteins provide protection against acid injury [@pone.0042204-Siqueira1]. Recent findings have shown that, in the *in vivo* AEP, protein film that naturally cover the tooth enamel surface, significant numbers of histatins (histatins 1, 3, and 5) remain intact [@pone.0042204-Siqueira1]. This observation suggests that the binding of intact histatins to the enamel surface confers the significant resistance against proteolytic degradation [@pone.0042204-McDonald1].

Only one protein shows increase level affected with the incorporation of fluoride on the HA surface. Basic Proline Rich Protein 2 (basic PRP2) was the only protein that demonstrated a significant increased protein level when HA group was compared with 2% NaF or 5% NaF groups. Interestingly, basic PRP2 has huge difference in physical-chemical characteristics than statherin and histatin 1. Basic PRP 2 is a salivary protein with significant amount of proline in its amino acid chain, non-phosphorylated and with an isoeletric point around 11.3. The function of basic PRPs is not well established in the oral cavity. However, those proteins have high affinity for dietary polyphenolic compounds (tannins) that probably provide protective effect against the potential deleterious action of these substances [@pone.0042204-Bennick1].

Understanding the composition-structure of AEP in HA surfaces treated with fluoride provide a new concept in the progress of oral diseases based on dental biofilm development such as dental caries and/or periodontal disease. Our results, despite the limitations of an *in vitro* study, presents new insights into the architecture of AEP on HA treated with fluoride and visualizes the quantitative and qualitative proteome modulation of this important tooth integument and consequently, the development of oral biofilm.
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